Article Information
History
- September 9, 2020.
Article Versions
- Version 1 (May 6, 2020 - 05:45).
- Version 2 (June 13, 2020 - 16:42).
- Version 3 (June 22, 2020 - 11:15).
- You are viewing Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Elizabeth T Chin, BS1,†,
- Benjamin Q Huynh, BS1,†,
- Lloyd A. C. Chapman2,
- Matthew Murrill, MD PhD2,
- Sanjay Basu, MD PhD3,4,5 and
- Nathan C Lo, MD PhD2,*
- 1Department of Biomedical Data Science, Stanford University, Stanford, CA, USA
- 2Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
- 3Center for Primary Care, Harvard Medical School, Boston, MA, USA
- 4Research and Population Health, Collective Health, San Francisco, CA, USA
- 5School of Public Health, Imperial College, London, UK
- ↵*Correspondence:
, Nathan C. Lo, MD PhD, Department of Medicine University of California, San Francisco, San Francisco, CA 94110 USA, nathan.lo{at}ucsf.edu
↵† Co-first author
Posted September 09, 2020.
Frequency of routine testing for COVID-19 in high-risk healthcare environments to reduce outbreaks
